Natixis »

Corcept Therapeutics Incorporated shares owned by Natixis

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Natixis

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.6M 110k 86.95
2026-03-31 $3.3k 81 40.31
2021-03-31 $221k 9.3k 23.76
2020-12-31 $243k 9.3k 26.13
2017-09-30 $219k 11k 19.29
2014-03-31 $50k 12k 4.35

More positions owned by Natixis

Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors (TSLA)
Spdr Series Trust St Str P500etf (SPYM)
Energy Transfer Com Ut Ltd Ptn (ET)
Broadcom (AVGO)
Oracle Corporation (ORCL)
JPMorgan Chase & Co. (JPM)

View all positions for Natixis

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Ingalls & Snyder
Renaissance Technologies
Vanguard Portfolio Management
Vanguard Capital Management
Parallel Advisors
FMR
State Street Corporation
AQR Capital Management
Geode Capital Management
First Trust Advisors
Tang Capital Management
UBS Group
Dimensional Fund Advisors
Charles Schwab Investment Management

View all funds holding Corcept Therapeutics Incorporated